The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study | European Journal of Medical Research | Full Text
High-dose Intravenous Immunoglobulin Treatment Increases Regulatory T Cells in Patients with Eosinophilic Granulomatosis with Polyangiitis | The Journal of Rheumatology
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial - eClinicalMedicine
Frontiers | Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
Dosing & Administration | GAMMAKED
IVIG Use in Renal Insufficiency or Transplantation
Frontiers | High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Privigen Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Desensitization Protocol Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab in Highly Sensitized Kidney Transplant Recipients - ATC Abstracts
Scleromyxoedema: Clinical Follow-up After Successful Treatment with High- dose Immunoglobulins Reveals Different Long-term Outcomes | HTML | Acta Dermato-Venereologica
Figure, Table 2: Dosing strategies of IVIG therapy. Contributed by Vijay B Arumugham] - StatPearls - NCBI Bookshelf
Intravenous immunoglobulin as clinical immune-modulating therapy | CMAJ
Intravenous Immunoglobulin (IVIG) Article
Frontiers | Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye
Frontiers | High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy | Nature Reviews Neurology
A clinical trial protocol for the study of intravenous immunoglobulin in patients with primary antibody immunodeficiency disorders
Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action | SpringerLink
Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA‐Sensitized Patients - Jordan - 2006 - American Journal of Transplantation - Wiley Online Library
Antibodies | Free Full-Text | Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence
10% liquid human immunoglobulin (KIOVIG®) for immunomodulation in autoimmune disorders | Immunotherapy
Intravenous Immunoglobulin: Overview, Uses of Intravenous Immunoglobulin, Pharmacology and Monitoring